| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Molecular Genetics (N.A.E., J.E.A., J.M., D.J.B.), Gene Expression Sciences (A.M.S., S.G.), and Cardiovascular Pharmacology (J.D., N.A.), SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406
Address all correspondence and requests for reprints to: Dr. Nabil A. Elshourbagy, Departments of Molecular Genetics, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.
Calcitonin gene-related peptide (CGRP) receptors (CGRP-Rs) are widely
distributed throughout the central and peripheral nervous systems. A
novel CGRP-R was identified from a porcine lung complementary DNA
library. Sequence analysis indicated that the CGRP-R is 462 amino acids
in length and shares 93% sequence identity with the human CGRP-R.
Northern blot analysis indicated a messenger RNA species of 5.4
kilobases, which is abundantly expressed in the lung. Ligand binding
studies of the cloned CGRP-R expressed in human embryonic kidney
(HEK-293) cells showed the presence of high affinity receptor for CGRP
with a Kd of 38.5 pM. The pharmacological
profiles of various ligands competing for [125I]CGRP
binding to the expressed receptor were in accordance with those for the
natural receptor. Binding of [125I]CGRP to the expressed
receptor was decreased in the presence of a nonhydrolyzable analog of
GTP, guanosine 5' (
-thio)-triphosphate. In functional studies, CGRP
stimulated the activation of adenylyl cyclase with an EC50
of 2.5 nM. The linear analog of CGRP, diacetoamidomethyl
cysteine CGRP, did not affect adenylyl cyclase activity on its own or
in the presence of CGRP. Furthermore, the CGRP receptor antagonists,
CGRP-(837)
, inhibited the CGRP-mediated response in a competitive
manner. Collectively, the binding and functional data demonstrate that
we have cloned a porcine CGRP type 1 receptor. The availability of the
CGRP-R complementary DNA will allow us to examine its participation in
pathophysiological processes.
This article has been cited by other articles:
![]() |
R. T. Dackor, K. Fritz-Six, W. P. Dunworth, C. L. Gibbons, O. Smithies, and K. M. Caron Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol. Cell. Biol., April 1, 2006; 26(7): 2511 - 2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Rorabaugh, M. A. Scofield, D. D. Smith, W. B. Jeffries, and P. W. Abel Functional Calcitonin Gene-Related Peptide Subtype 2 Receptors in Porcine Coronary Arteries Are Identified as Calcitonin Gene-Related Peptide Subtype 1 Receptors by Radioligand Binding and Reverse Transcription-Polymerase Chain Reaction J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1086 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Aiyar, R. A. Daines, J. Disa, P. A. Chambers, C. F. Sauermelch, M.-J. Quiniou, N. Khandoudi, B. Gout, S. A. Douglas, and R. N. Willette Pharmacology of SB-273779, a Nonpeptide Calcitonin Gene-Related Peptide 1 Receptor Antagonist J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 768 - 775. [Abstract] [Full Text] |
||||
![]() |
J. P. Hinson, S. Kapas, and D. M. Smith Adrenomedullin, a Multifunctional Regulatory Peptide Endocr. Rev., April 1, 2000; 21(2): 138 - 167. [Abstract] [Full Text] |
||||
![]() |
W. Nowak, N. Parameswaran, C. S. Hall, N. Aiyar, H. V. Sparks, and W. S. Spielman Novel regulation of adrenomedullin receptor by PDGF: role of receptor activity modifying protein-3 Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1322 - C1331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |